Testosterone Replacement Therapy in the Aged Male: Monitoring Patients' Quality of Life Utilizing Scoring Systems.
lower urinary tract symptoms
mental health
quality of life
sexual health
testosterone replacement treatment
well-being
Journal
International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
01
2022
accepted:
30
08
2022
entrez:
15
9
2022
pubmed:
16
9
2022
medline:
16
9
2022
Statut:
epublish
Résumé
Hypogonadism has been associated with significant deterioration of well-being. In the aging male, late-onset hypogonadism affects sexual life, mental health, levels of energy, lower urinary tract symptoms and, therefore, quality of life may be found significantly deteriorated. Testosterone replacement or supplementation therapy has been found efficient to reverse the adverse effects of hypogonadism and improve quality of life. Scales and questionnaires assessing the general health, urinary symptoms, sexual health, and cognition can provide a thorough assessment of the clinical syndrome, optimize treatment, assist the follow-up, and facilitate referrals to other specialties depending on the chief complaint. A systematic assessment might combine several tools, but the optimal ones and the exact usage is unknown. In this narrative review, we are flipping through the literature presenting the available tools per domain for the assessment of quality of life in men on testosterone replacement therapy and we discuss the optimal usage.
Identifiants
pubmed: 36105846
doi: 10.2147/IJGM.S253183
pii: 253183
pmc: PMC9464626
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
7123-7130Informations de copyright
© 2022 Tsampoukas et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Int J Androl. 2010 Aug 1;33(4):574-80
pubmed: 19780865
F1000Res. 2019 Mar 25;8:
pubmed: 30984376
Aging Male. 2020 Dec;23(5):403-410
pubmed: 30269622
J Androl. 2003 Sep-Oct;24(5):688-98
pubmed: 12954659
J Sex Med. 2011 Nov;8(11):3204-13
pubmed: 21834870
Prostate. 1993;23(2):99-106
pubmed: 7690956
Am J Transl Res. 2021 Nov 15;13(11):12860-12867
pubmed: 34956501
Am J Mens Health. 2018 Sep;12(5):1403-1408
pubmed: 27256990
Ageing Res Rev. 2021 May;67:101301
pubmed: 33610812
Endocr J. 2012;59(12):1099-105
pubmed: 22972022
World J Mens Health. 2013 Apr;31(1):47-52
pubmed: 23658865
J Clin Endocrinol Metab. 2015 Aug;100(8):2956-62
pubmed: 26158605
Urol Int. 2022;106(6):539-552
pubmed: 34856556
BJU Int. 2009 May;103(9):1179-83
pubmed: 19154450
Aging Male. 2006 Dec;9(4):189-93
pubmed: 17178553
Support Care Cancer. 2022 Apr;30(4):3141-3150
pubmed: 34878587
Aging Male. 2015;18(3):169-74
pubmed: 26075538
J Sex Med. 2014 Feb;11(2):553-62
pubmed: 24344902
Ann Endocrinol (Paris). 2014 May;75(2):128-31
pubmed: 24793989
J Sex Med. 2017 Sep;14(9):1104-1115
pubmed: 28781213
Andrologia. 2011 Feb;43(1):52-6
pubmed: 21219383
Best Pract Res Clin Endocrinol Metab. 2022 Jan;36(1):101599
pubmed: 34799236
Lancet. 2004 Jul 17-23;364(9430):273-83
pubmed: 15262106
Asian J Androl. 2014 Mar-Apr;16(2):270-3
pubmed: 24435051
J Sex Med. 2018 Jul;15(7):997-1009
pubmed: 29960633
BMC Public Health. 2020 Feb 19;20(1):257
pubmed: 32075614
J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):401-7
pubmed: 16601644
Aging Male. 2010 Dec;13(4):242-6
pubmed: 20795793
Health Qual Life Outcomes. 2003 May 01;1:15
pubmed: 12747807
Arab J Urol. 2016 Mar;14(1):31-6
pubmed: 26966591
Int Neurourol J. 2021 Mar;25(1):12-22
pubmed: 33504130
Curr Opin Endocrinol Diabetes Obes. 2019 Feb;26(1):60-65
pubmed: 30507702
Andrology. 2013 Jul;1(4):576-82
pubmed: 23606509
J Psychiatr Ment Health Nurs. 2011 Oct;18(8):744-50
pubmed: 21896118
Can J Urol. 2007 Dec;14 Suppl 1:63-8
pubmed: 18163948
J Affect Disord. 2021 Jun 15;289:66-73
pubmed: 33945916
Psychol Assess. 2013 Jun;25(2):331-8
pubmed: 23244637
Postgrad Med. 2008 Sep;120(3):130-53
pubmed: 18824832
Andrologia. 2017 May;49(4):
pubmed: 27389320
Clin Endocrinol (Oxf). 2022 Feb;96(2):227-235
pubmed: 34816471
Expert Rev Endocrinol Metab. 2021 Jan;16(1):1-8
pubmed: 33345656
World J Mens Health. 2018 May;36(2):103-109
pubmed: 29623698
J Sex Med. 2014 Jan;11(1):262-72
pubmed: 23937088
Korean J Urol. 2011 Aug;52(8):566-71
pubmed: 21927705
Eur Endocrinol. 2013 Mar;9(1):59-64
pubmed: 30349612
Andrology. 2018 Jul;6(4):513-524
pubmed: 30134082
Eur Urol. 2016 Jun;69(6):1083-90
pubmed: 26874809
J Gend Specif Med. 2001;4(2):49-53
pubmed: 11480098
Andrologia. 2020 Oct;52(9):e13768
pubmed: 32706428
Exp Ther Med. 2016 Mar;11(3):853-863
pubmed: 26998003
PLoS Med. 2019 Nov 12;16(11):e1002960
pubmed: 31714912
J Affect Disord. 1998 Mar;48(2-3):157-61
pubmed: 9543205
Int J Impot Res. 2022 Jan 24;:
pubmed: 35075296
J Sex Med. 2013 Jun;10(6):1612-27
pubmed: 23551886
J Endocrinol Invest. 2021 May;44(5):1053-1063
pubmed: 32865776
World J Urol. 2014 Aug;32(4):1049-54
pubmed: 24135918
Andrologia. 2006 Apr;38(2):48-53
pubmed: 16529575
Andrologia. 2016 Mar;48(2):198-202
pubmed: 25988884
Dialogues Clin Neurosci. 2006;8(2):207-15
pubmed: 16889106
F1000Res. 2019 Feb 25;8:
pubmed: 30828436
Front Endocrinol (Lausanne). 2019 Jul 05;10:353
pubmed: 31333578
Investig Clin Urol. 2020 May;61(3):242-249
pubmed: 32377599
Aging Male. 2018 Jun;21(2):99-105
pubmed: 28920756
Urology. 1997 Jun;49(6):822-30
pubmed: 9187685
BJU Int. 2010 Dec;106(11):1700-3
pubmed: 20575982
Andrology. 2014 Mar;2(2):205-211
pubmed: 24574152